Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Treatment of Venous Thromboembolism with Edoxaban over 18 Months: Results from ETNA-VTE Europe
Giancarlo Agnelli, Ulrich Hoffmann, Pierre Hainaut, Seán Gaine, Cihan Ay, Michiel Coppens, Marc Schindewolf, David Jiménez, Eva‐Maria Fronk, José Souza, Petra Laeis, Peter Bramlage, Bernd Brüggenjürgen, Pierre Lévy, Alexander T. Cohen (2025). Treatment of Venous Thromboembolism with Edoxaban over 18 Months: Results from ETNA-VTE Europe. , DOI: https://doi.org/10.1055/a-2497-4089.
Article325 days agoRight ventricle assessment in patients with pulmonary embolism at low risk for death based on clinical models: an individual patient data meta-analysis
Cecilia Becattini, Giorgio Maraziti, David R. Vinson, A. Ng, Paul L. den Exter, Benoît Côté, Simone Vanni, Rami Doukky, Danai Khemasuwan, Anthony J. Weekes, Thiago Horta Soares, Savaş Özsu, Hernan Polo Friz, Serhat Erol, Giancarlo Agnelli, David Jiménez (2021). Right ventricle assessment in patients with pulmonary embolism at low risk for death based on clinical models: an individual patient data meta-analysis. , 42(33), DOI: https://doi.org/10.1093/eurheartj/ehab329.
Article325 days agoETNA VTE Europe: A contemporary snapshot of patients treated with edoxaban in clinical practice across eight European countries
Alexander T. Cohen, Ulrich Hoffmann, Pierre Hainaut, Seán Gaine, Cihan Ay, Michiel Coppens, Marc Schindewolf, David Jiménez, Bernd Brüggenjürgen, Pierre Lévy, Petra Laeis, Eva‐Maria Fronk, Wolfgang Zierhut, Thomas Malzer, Marius Constantin Manu, Paul‐Egbert Reimitz, Peter Bramlage, Giancarlo Agnelli (2020). ETNA VTE Europe: A contemporary snapshot of patients treated with edoxaban in clinical practice across eight European countries. , 82, DOI: https://doi.org/10.1016/j.ejim.2020.08.014.
Article325 days agoETNA-VTE Europe: Benefits and risks of venous thromboembolism treatment using edoxaban in the first 3 months
Marius Constantin Manu, Paul‐Egbert Reimitz, Peter Bramlage, Alexander T. Cohen, Giancarlo Agnelli, Ulrich Hoffmann, Pierre Hainaut, Seán Gaine, Cihan Ay, Michiel Coppens, Marc Schindewolf, David Jiménez, Bernd Brüggenjürgen, Pierre Lévy, Petra Laeis, Eva‐Maria Fronk, Wolfgang Zierhut, Thomas Malzer (2020). ETNA-VTE Europe: Benefits and risks of venous thromboembolism treatment using edoxaban in the first 3 months. , 196, DOI: https://doi.org/10.1016/j.thromres.2020.09.001.
Article325 days agoAssociation between index venous thromboembolism (VTE) event and 12-months outcomes for patients in routine clinical practice enrolledin the Edoxaban Treatment in routine cliNical prActice for patients with acute VTE in Europe (ETNA-VTE-Europe) registry
Michiel Coppens, Alexander T. Cohen, Cihan Ay, Pierre Hainaut, Ulrich Hoffmann, Seán Gaine, David Jiménez, Marc Schindewolf, Bernd Brüggenjürgen, Pierre Lévy, Julio López Bastida, Éric Vicaut, Peter Bramlage, Giancarlo Agnelli (2020). Association between index venous thromboembolism (VTE) event and 12-months outcomes for patients in routine clinical practice enrolledin the Edoxaban Treatment in routine cliNical prActice for patients with acute VTE in Europe (ETNA-VTE-Europe) registry. , DOI: https://doi.org/10.7892/boris.144861.
Article325 days ago